☆ 4.6 Article

Transferability of real-world data across borders for regulatory and health technology assessment decision-making

FRONTIERS IN MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World

Douglas McNair et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications

Christina A. Purpura et al.

Summary: During the period from January 2019 to June 2021, the US FDA approved 116 medical products, with 88 of them including RWE studies intended to provide evidence of safety or effectiveness. Among these studies, 65 influenced the FDA's final decision, and 38 were included in product labels. The approvals spanned 18 therapeutic areas and highlighted various quality issues related to RWE study. Future guidance on FDA's evidentiary expectations may emphasize the importance of real-world data selection and study design.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018-2019

Sini Marika Eskola et al.

Summary: This study analyzed the use of RWD/RWE in the pre-authorization phase of new medicines evaluated by the EMA in 2018-2019. It found that RWE signatures were commonly used in drug development, especially in the discovery and life-cycle management stages. Therapeutic areas such as oncology, hematology, and anti-infectives showed higher utilization of RWD/RWE in their full development phase.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework

Nicolle M. Gatto et al.

Summary: This study presents a structured framework for conducting feasibility assessments to determine if a data source is fit for decision making, helping ensure justification and transparency throughout study development.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Real-World Data in the Postapproval Setting as Applied by the EMA and the US FDA

Sarah Mofid et al.

Summary: This study analyzes the regulatory decisions in postmarketing surveillance activities that suggest the use of real-world data (RWD) approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). The findings show an increasing use of RWD to support regulatory decision-making, with registries being the most common source of data. The study highlights the potential of RWD to inform regulatory decisions on clinical interventions' benefits and risks.

CLINICAL THERAPEUTICS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Real World Data in Health Technology Assessment of Complex Health Technologies

Milou A. Hogervorst et al.

Summary: This study assessed the challenges and acceptance of real-world data (RWD) in health technology assessment (HTA) organizations. The results showed that patient registries were the most accepted RWD source, while editorials and expert opinions were the least accepted. Lack of necessary RWD sources and existing policy structures were identified as the main barriers to accepting RWD.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis

Ryan M. Barber et al.

Summary: Timely, accurate, and comprehensive estimation of SARS-CoV-2 infection rates are crucial for understanding past infections and transmission risks. This study provided a novel approach to estimate global and location-specific infections, combining data sources and correcting biases for more reliable estimates. The findings show staggering impacts of COVID-19 on the global population, highlighting the importance of continued research and policy responses.

LANCET (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Health Canada Usage of Real World Evidence (RWE) in Regulatory Decision Making compared with FDA/EMA usage based on publicly available information

Catherine Lau et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2022)

添加到收藏夹

Review Health Care Sciences & Services

Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers

Maria Kamusheva et al.

Summary: This study aimed to identify the main barriers for applying real-world evidence in health technology assessment in Central and Eastern European countries. A mixed methods approach was employed, and the main barriers were summarized in five groups: technical, regulatory, clinical, scientific, and perceptional. Further research should focus on developing consensus-based guidelines to improve the harmonization and standardization of real-world evidence.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis

Mototsugu Tanaka et al.

Summary: The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has approved hundreds of new drugs in recent years. Among 400 new drugs approved in Japan from 2008 to 2019, 20% were first-in-world approvals. The drug lag has decreased significantly in recent years, although it remains substantial in areas such as neurology and psychiatry which have fewer new drug approvals.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Oncology

Current treatment and recent progress in gastric cancer

Smita S. Joshi et al.

Summary: Gastric cancer is a common cause of cancer death worldwide, with treatment options including systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy. Classification and biomarkers for gastric cancer help in personalized therapy and identifying populations most likely to benefit from immunotherapy and targeted therapy.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries

Cassandra Nemzoff et al.

BMJ GLOBAL HEALTH (2021)

添加到收藏夹

Article Economics

Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials

Dony Patel et al.

Summary: The study found that the number of SAT-based HTA submissions increased 13-fold between 2011 and 2019, with around 65% focused on oncology or hem-oncology. Of the 226 submissions, approximately 52% used some form of EC data, with an overall acceptance rate of 48% and 59% when including RWD EC data. The use of RWD ECs increased over time while prior trial ECs decreased, impacting acceptance rates.

VALUE IN HEALTH (2021)

添加到收藏夹

Article Health Care Sciences & Services

Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance

Ashley Jaksa et al.

Summary: There is a growing interest in incorporating real-world evidence (RWE) into decision-making processes among decision-makers. Stakeholders have issued multiple recommendation documents to set RWE standards, but the fragmented nature of these documents poses challenges for researchers and decision-makers seeking guidance. This paper provides a structure to organize RWE recommendations, identify consensus and gaps, and offers pathways for researchers to generate RWE, discussing how decision-makers can transition from fragmented recommendations to comprehensive guidance.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies

Shirley Wang et al.

Summary: The translation discusses a structured template developed by a public-private consortium for planning and reporting on real world evidence studies, aiming to guide reproducible study designs, increase transparency, and enhance validity assessment.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

Andrew Campbell et al.

Summary: This study presents the ethnic and racial background of 877 SCD patients from Ghana, the USA, Italy, and the UK. Different ethnic backgrounds were observed in each country, suggesting that genetic and environmental factors may influence the clinical phenotype and research outcomes in SCD populations.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why

Mwango Kashoki et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden

Lars Pedersen et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval

Roberta Joppi et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

添加到收藏夹

Review Public, Environmental & Occupational Health

Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions

Jasmanda Wu et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

添加到收藏夹

Article Health Care Sciences & Services

Real-world evidence use in assessments of cancer drugs by NICE

Ash Bullement et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2020)

添加到收藏夹

Article Health Care Sciences & Services

The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries

Bertalan Nemeth et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)

添加到收藏夹

Article Medicine, General & Internal

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos et al.

LANCET (2020)

添加到收藏夹

Article Economics

Use of Real-World Evidence to Support FDA Approval of Oncology Drugs

Bruce A. Feinberg et al.

VALUE IN HEALTH (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real-World Evidence for Regulatory Decisions

Nicolle M. Gatto et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Article Health Care Sciences & Services

Revisiting out-of-pocket requirements: trends in spending, financial access barriers, and policy in ten high-income countries

Thomas Rice et al.

BMC HEALTH SERVICES RESEARCH (2018)

添加到收藏夹

Article Primary Health Care

Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions

Eriko Onishi et al.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2017)

添加到收藏夹

Article Health Care Sciences & Services

REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE

Olena Mandrik et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2015)

添加到收藏夹

Review Oncology

Comparison of International Guidelines on the Accompanying Therapy for Advanced Gastric Cancer: Reasons for the Differences

Katrin Bauer et al.

JOURNAL OF GASTRIC CANCER (2015)

添加到收藏夹

Editorial Material Oncology

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

C. M. Booth et al.

BRITISH JOURNAL OF CANCER (2014)

添加到收藏夹

Review Health Care Sciences & Services

Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application

Ron Goeree et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.